Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |